Shares of Masimo Co. (NASDAQ:MASI – Get Free Report) have received an average rating of “Moderate Buy” from the seven ...

Joe Kiani Co-Founder Masimo Corp. The latest legal battle between Irvine-based medical device maker Masimo Corp. and Apple ...

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...

MAMO sees a 30.7% increase in non-GAAP operating income in Q3 2024. Healthcare segment revenues increase 11.5%, driving ...

Masimo Corp (MASI) reports robust healthcare revenue growth and improved margins, while navigating non-healthcare segment ...

Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Masimo Corp.'s attorneys are betting that evidence of a “deep mind meld” between a Masimo co-founder and a key employee hired ...

周三，Raymond James将Masimo Corp. (NASDAQ:MASI)的评级从"市场表现"上调至"跑赢大市"。该公司为Masimo股票设定了170.00美元的目标价。此次上调评级是基于对公司盈利增长和利润率扩张潜力的积极展望。 Raymond James列举了几个上调评级的理由，包括预期Masimo的盈利预估可能会上升。分析师指出，在剥离消费者业务部门后，Masimo的发展路径变得 ...